Your browser is no longer supported. Please, upgrade your browser.
ABBV AbbVie Inc. weekly Stock Chart
AbbVie Inc.
IndexS&P 500 P/E38.95 EPS (ttm)2.23 Insider Own0.10% Shs Outstand1.49B Perf Week-0.85%
Market Cap129.51B Forward P/E8.92 EPS next Y9.75 Insider Trans13.49% Shs Float1.48B Perf Month5.97%
Income3.32B PEG11.13 EPS next Q2.21 Inst Own73.00% Short Float4.80% Perf Quarter30.40%
Sales32.87B P/S3.94 EPS this Y4.80% Inst Trans3.23% Short Ratio9.05 Perf Half Y13.03%
Book/sh-5.55 P/B- EPS next Y9.23% ROA5.60% Target Price94.80 Perf Year-3.71%
Cash/sh7.15 P/C12.16 EPS next 5Y3.50% ROE-39.10% 52W Range62.66 - 92.99 Perf YTD-5.65%
Dividend4.72 P/FCF19.31 EPS past 5Y7.60% ROI21.80% 52W High-6.46% Beta0.97
Dividend %5.43% Quick Ratio1.00 Sales past 5Y11.80% Gross Margin77.00% 52W Low38.81% ATR1.57
Employees30000 Current Ratio1.20 Sales Q/Q3.00% Oper. Margin20.00% RSI (14)60.83 Volatility1.22% 1.84%
OptionableYes Debt/Eq- EPS Q/Q-30.00% Profit Margin9.80% Rel Volume0.77 Prev Close86.72
ShortableYes LT Debt/Eq- EarningsNov 01 BMO Payout191.10% Avg Volume7.84M Price86.98
Recom2.10 SMA200.08% SMA507.88% SMA20014.30% Volume6,017,727 Change0.30%
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Jun-26-19Upgrade SVB Leerink Mkt Perform → Outperform $88
May-28-19Initiated Goldman Neutral
Apr-29-19Upgrade BMO Capital Markets Underperform → Market Perform
Mar-25-19Downgrade Argus Buy → Hold
Jan-23-19Initiated UBS Neutral $91
Jan-03-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Initiated Standpoint Research Buy
Oct-22-18Reiterated SunTrust Buy $157 → $135
Oct-04-18Reiterated BofA/Merrill Buy $107 → $106
Jun-01-18Downgrade Piper Jaffray Overweight → Neutral
May-30-18Downgrade Credit Suisse Neutral → Underperform
Jan-30-18Reiterated Morgan Stanley Equal-Weight $99 → $131
Jan-29-18Downgrade Leerink Partners Outperform → Mkt Perform
Oct-30-17Reiterated Leerink Partners Outperform $108 → $107
Oct-02-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-25-17Downgrade UBS Buy → Neutral $79 → $92
Aug-17-17Initiated Evercore ISI Outperform $95
Dec-08-19 07:30AM  New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYXTO® (venetoclax) Combination in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) PR Newswire
Dec-07-19 09:00AM  More than Seven-Year Analysis of Early Treatment with IMBRUVICA® (ibrutinib) Monotherapy Showed Improved Progression-Free Survival in Patients with Mantle Cell Lymphoma (MCL) that Relapsed or Were Unresponsive to Prior Regimen PR Newswire
07:33AM  Extended Follow-up Phase 3 Data Underscore Sustained Efficacy and Safety of IMBRUVICA® (ibrutinib) in the Treatment of Chronic Lymphocytic Leukemia (CLL) PR Newswire
07:30AM  IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Data Show High Rates of Disease Clearance in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL) PR Newswire
Dec-06-19 04:30PM  Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimers Disease (CTAD) Meeting GlobeNewswire
07:27AM  Belgium's UCB says psoriasis drug beats AbbVie's Humira in trial Reuters
06:00AM  AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for SKYRIZI (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis CNW Group
Dec-05-19 10:57AM  Merck Stock Is On An Upswing In 2019 Should You Buy This Pharma Stock? Investor's Business Daily
09:07AM  J&J Stock Witnesses Volatility in '19: What to Expect in 2020 Zacks
Dec-04-19 10:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
Dec-03-19 09:26AM  Where to Buy Booming Biotech ETFs Investopedia
05:06AM  [video]AbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis Drug
Dec-02-19 05:45PM  AbbVie (ABBV) Stock Moves -0.79%: What You Should Know Zacks
02:29PM  Disney Stock Is Loved by Wall Street. Its Bonds? Not So Much.
09:18AM  3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - December 02, 2019 Zacks
Dec-01-19 09:30AM  AbbVie (ABBV) Up 10.3% Since Last Earnings Report: Can It Continue? Zacks
Nov-30-19 05:14PM  Did Hedge Funds Drop The Ball On AbbVie Inc (ABBV) ? Insider Monkey
Nov-29-19 09:15AM  Market Serves Up More Records for Thanksgiving Zacks
Nov-28-19 07:00AM  The 3 Worst-Performing Health Care Stocks of 2019 So Far
Nov-27-19 11:22PM  Why some corporate bond investors see higher risk in higher ratings Financial Times
07:06PM  3 Stocks for Value Investors to Buy as Market Reaches New High Zacks
12:33PM  Johnson Adviser Warns of Chance of Hung Parliament: U.K. Votes Bloomberg
11:02AM  Tory Prime Minister Johnson has held secret talks with U.S. about privatizing National Health Service, Labour rival claims MarketWatch
Nov-26-19 05:54PM  BeiGene Shares Climb Nearly 50% After Amgen Deal
12:43PM  Best Dividend Stocks for December 2019 Investopedia
09:20AM  3 Top Dividend Stocks to Maximize Your Retirement Income - November 26, 2019 Zacks
Nov-25-19 08:56AM  Timing the Market, Is it Possible? - November 25, 2019 Zacks
Nov-22-19 11:31AM  Pharma Stock Roundup: FDA Nod to NVS' & AZN's Drugs, BMY-CELG Merger Closes Zacks
10:08AM  AstraZeneca shares rise on early U.S. approval for leukemia drug Reuters
Nov-21-19 08:30AM  AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting PR Newswire
04:00AM  Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoons BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration GlobeNewswire
Nov-20-19 09:55AM  Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - November 20, 2019 Zacks
09:22AM  Myovant Up on Successful Completion of Prostate Cancer Study Zacks
08:00AM  Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology CNW Group
07:58AM  5 Corporate Giants That Popped After Latest Earnings Release Zacks
Nov-19-19 10:33AM  Drug Legislation Likely to Dry Up Biotech Funding
10:23AM  Pfizer Gets FDA Approval for Biosimilar of AbbVie's Humira Zacks
05:00AM  AbbVie- On the Cutting Edge MoneyShow
Nov-18-19 08:00AM  AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes PR Newswire
Nov-17-19 03:40PM  AbbVie's Humira on Pace to Become Biggest Seller by 2024
Nov-15-19 07:12AM  Pharma Stock Roundup: MRK, GSK, ABBV, LLY's Pipeline & Regulatory Updates Zacks
06:41AM  4 Big Drugmakers to Bet on After a Great Earnings Season Zacks
Nov-14-19 11:00PM  Credit market fears of downgrades have not materialised Financial Times
06:24PM  Seth Klarman Exits Allergan, Buys 3 New Positions in 3rd Quarter
08:28AM  Exicures shares up on Allergan partnership MarketWatch
06:00AM  Beware of Runs on Bond Funds
05:01AM  AbbVie Sold $30 Billion in Bonds, and Two More Numbers to Know
Nov-13-19 02:34PM  Should Investors Add Johnson & Johnson Stock to Their Shopping Lists? InvestorPlace
12:03PM  AbbVie Takes on Debt to Buy Allergan
10:46AM  AbbVies $30 Billion Bond Sale Was Wall Streets Biggest This Year
09:30AM  Abbott Labs Chooses an Insider to Be Its New CEO
03:52AM  Cash Stashes Dwindle as Markets Crest and Powell Speaks: Market Recon
Nov-12-19 09:45PM  AbbVie Prices $30 Billion of Senior Unsecured Notes PR Newswire
05:12PM  AbbVie Sells $30 Billion of Bonds to Fund Allergan Acquisition Bloomberg
04:40PM  US Indexes End the Day Higher Tuesday
02:11PM  Corporations Pile Into Bond Market as Borrowing Costs Drop Bloomberg
11:15AM  New Positive Data for RINVOQ (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 2019 ACR/ARP Annual Meeting PR Newswire
08:31AM  The Zacks Analyst Blog Highlights: Toyota, Netflix, AbbVie, Gilead and Fiserv Zacks
06:56AM  AbbVie Rises 3%
06:46AM  AbbVie sells $30bn of bonds to finance Allergan takeover Financial Times
05:00AM  AbbVie Eyes Up to $28 Billion Bond Sale to Finance Allergan Deal: Report
Nov-11-19 01:50PM  Top Research Reports for Toyota, Netflix & AbbVie Zacks
01:12PM  Mario Gabelli Continues to Buy AbbVie, Axalta
09:03AM  AbbVie Eyes Approval for Imbruvica+Rituxan in First-Line CLL Zacks
Nov-08-19 09:00AM  Psst! Want the Secret to Picking Winning Stocks? Keep Reading.
08:45AM  10 Medical Marijuana Stocks to Cure Your Portfolio InvestorPlace
07:30AM  AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA® (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia PR Newswire
05:50AM  AbbVie Rises 3%
Nov-07-19 08:41PM  AbbVie Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Allergan Notes PR Newswire
10:49AM featured highlights include: Group 1 Automotive, AbbVie, Brinker International, Hewlett Packard Enterprise and Bristol-Myers Squibb Zacks
10:18AM  AbbVie Inc. -- Moody's assigns Baa2 to AbbVie's new sr. notes; stable outlook Moody's
Nov-06-19 03:06PM  AbbVie Announces Launch of Private Offering of Senior Unsecured Notes PR Newswire
05:11AM  Should You Worry About AbbVie Inc.'s (NYSE:ABBV) CEO Pay Cheque? Simply Wall St.
Nov-05-19 06:16PM  Vanguard Health Care Fund Sells Out of Allergan
11:02AM  Allergan (AGN) Meets Q3 Earnings Estimates, Ups '19 Sales View Zacks
10:48AM  Allergan's Q3 Sales Get A Facelift From Botox; AbbVie Deal On Track Benzinga
10:11AM  The Zacks Analyst Blog Highlights: Group 1 Automotive, AbbVie, Brinker International, Hewlett Packard and Bristol-Myers Squibb Zacks
04:40AM  [video]Allergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie Takeover
Nov-04-19 01:00PM  Value Biotech ETFs & Stocks to Buy Now Zacks
11:54AM  ImmunoGen (IMGN) Q3 Earnings & Sales Beat, Shares Rally Zacks
11:20AM  Eaton Vance Worldwide Health Sciences Fund Buys 2 Stocks
10:08AM  Top Ranked Income Stocks to Buy for November 4th Zacks
09:10AM  Dr. Reddy's (RDY) Q2 Earnings and Revenues Increase Y/Y Zacks
09:08AM  Novo Nordisk (NVO) Q3 Earnings Beat Estimates, Revenues Miss Zacks
09:07AM  5 High-Flying Stocks Near 52-Week High That Can Scale Higher Zacks
08:44AM  When Does Market Timing Actually Work? - November 04, 2019 Zacks
08:31AM  AbbVie to Showcase Depth of Immunology Portfolio and Pipeline at the 2019 ACR/ARP Annual Meeting PR Newswire
01:00AM  Rounding Up Big Pharma Earnings Morningstar
Nov-03-19 09:47PM  Edited Transcript of ABBV earnings conference call or presentation 1-Nov-19 1:00pm GMT Thomson Reuters StreetEvents
Nov-02-19 11:56AM  Barron's Picks And Pans: AbbVie, Alibaba, Fiat Chrysler, Garmin And More Benzinga
07:00AM  Starbucks, AbbVie, and 4 Others Announce Dividend Hikes
Nov-01-19 07:02PM  5 High-Yield Stocks That Can Keep On Giving
04:21PM  AbbVie Stock Jumps On Strong Quarter As Allergan Takeover Looms Investor's Business Daily
04:21PM  S&P500 and Nasdaq hit new records after October jobs numbers beat expectations MarketWatch
03:24PM  6 Top Stock Trades for Monday: BABA, PINS, CVX InvestorPlace
02:47PM  AbbVie (ABBV) Beats on Q3 Earnings & Sales, Tweaks EPS View Zacks
11:28AM  AbbVie Stock Jumps On Strong Quarter As Allergan Takeover Looms Investor's Business Daily
11:07AM  WIll Allergan (AGN) Beat Estimates This Earnings Season? Zacks
10:55AM  Pharma Stock Roundup: MRK, PFE, GSK, BMY Q3 Earnings, Other Updates Zacks
10:10AM  AbbVie says multiple parties vying for assets related to Allergan deal approval Reuters
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide molecule gonadotropin-releasing hormone antagonist. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; Calico Life Sciences LLC; Cystic Fibrosis Foundation; and Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHMOND TIMOTHY J.EVP, Chief HR OfficerSep 27Sale75.0215,5151,163,8730Oct 01 05:52 PM
Schumacher Laura JVice ChairmanSep 16Buy70.4225,0001,760,523164,838Sep 18 04:25 PM
Donoghoe NicholasSVP, Enterprise InnovationAug 29Buy66.197,525498,05713,090Aug 30 04:08 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsAug 16Buy64.4415,5521,002,16965,304Aug 20 04:16 PM
AUSTIN ROXANNE SDirectorAug 01Buy65.6625,0001,641,400117,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 31Buy66.0230,0001,980,69092,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 30Buy66.3510,000663,50062,114Jul 31 04:46 PM
Gosebruch Henry OEVP, Chief Strategy OfficerJul 29Buy67.2830,0002,018,38575,763Jul 31 04:46 PM
AUSTIN ROXANNE SDirectorJun 26Buy67.5011,500776,25052,114Jun 28 04:47 PM
CHASE WILLIAM JEVP, Finance & AdministrationJun 26Buy67.3030,4002,045,920169,552Jun 28 04:47 PM
RAPP EDWARD JDirectorJun 26Buy67.307,500504,75030,662Jun 28 04:48 PM
Durkin Brian LVP, ControllerMar 25Sale79.6947537,8539,121Mar 25 04:34 PM
Schumacher Laura JVice ChairmanMar 14Sale80.0025,0002,000,000139,838Mar 15 05:53 PM
SALEKI-GERHARDT AZITAEVP, OperationsMar 05Sale79.0315,7971,248,48093,312Mar 06 05:03 PM
Schumacher Laura JVice ChairmanDec 28Sale90.0025,0002,250,000134,322Jan 02 04:49 PM
CHASE WILLIAM JEVP, Finance & AdministrationDec 12Sale90.0060,0005,400,000104,863Dec 14 05:12 PM
GONZALEZ RICHARD AChairman of the Board and CEODec 11Sale88.7516,8501,495,438286,203Dec 13 04:56 PM